Bioelectronics Corp (BIEL)

[Simpsonly]

I know I never trust redactions; they manipulate and distort the truth.
Also, if, as and when the company decides it is in the best interests of itself, to protect its business enterprise, and its shareholders, to issue a press release confirming its status with respect to its 510(k) application to the FDA for OTC Clearance for the sale of ActiPatch here in the U.S., it will do so. Until then it is blatantly remaining silent, as it should and as it must! Security laws require that!